Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash from Financing Activities: 2024-2025

Historic Cash from Financing Activities for Incannex Healthcare (IXHL) over the last 1 years, with Sep 2025 value amounting to $67.2 million.

  • Incannex Healthcare's Cash from Financing Activities rose 129286.54% to $67.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year change of. This contributed to the annual value of $21.4 million for FY2025, which is N/A change from last year.
  • Latest data reveals that Incannex Healthcare reported Cash from Financing Activities of $67.2 million as of Q3 2025, which was up 599.61% from $9.6 million recorded in Q2 2025.
  • Incannex Healthcare's Cash from Financing Activities' 5-year high stood at $67.2 million during Q3 2025, with a 5-year trough of -$52,000 in Q3 2024.
  • Its 2-year average for Cash from Financing Activities is $17.7 million, with a median of $7.7 million in 2025.
  • Data for Incannex Healthcare's Cash from Financing Activities shows a peak YoY spiked of 129,286.54% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Incannex Healthcare's Cash from Financing Activities stood at $4.1 million in 2024, then skyrocketed by 129,286.54% to $67.2 million in 2025.
  • Its last three reported values are $67.2 million in Q3 2025, $9.6 million for Q2 2025, and $7.7 million during Q1 2025.